{
    "Title": "P53 and Cancer-Associated Sialylated Glycans Are Surrogate Markers of Cancerization of the Bladder Associated with Schistosoma haematobium Infection",
    "URL": "https://doi.org/10.1371/journal.pntd.0003329",
    "Published": "December 11, 2014",
    "Subject_Areas": [
        "Bladder cancer",
        "Bladder",
        "Lesions",
        "Schistosoma haematobium",
        "Parasitic diseases",
        "Squamous cell carcinoma",
        "Eggs",
        "Biomarkers"
    ],
    "Authors": {
        "Júlio Santos": [
            "Experimental Pathology and Therapeutics group, Portuguese Institute for Oncology of Porto, Porto, Portugal",
            "Clínica Sagrada Esperança, Luanda, Angola"
        ],
        "Elisabete Fernandes": [
            "Experimental Pathology and Therapeutics group, Portuguese Institute for Oncology of Porto, Porto, Portugal",
            "Grupo de Investigação em Cancro Digestivo (GICD), Porto, Portugal"
        ],
        "José Alexandre Ferreira": [
            "Experimental Pathology and Therapeutics group, Portuguese Institute for Oncology of Porto, Porto, Portugal",
            "Department of Chemistry of the University of Aveiro, Aveiro, Portugal"
        ],
        "Luís Lima": [
            "Experimental Pathology and Therapeutics group, Portuguese Institute for Oncology of Porto, Porto, Portugal",
            "Research Department, LPCC-Portuguese League Against Cancer (NRNorte), Porto, Portugal",
            "Núcleo de Investigação em Farmácia – Centro de Investigação em Saúde e Ambiente (CISA), School of Allied Health Sciences – Polytechnic Institute of Porto, Porto, Portugal"
        ],
        "Ana Tavares": [
            "Experimental Pathology and Therapeutics group, Portuguese Institute for Oncology of Porto, Porto, Portugal",
            "Department of Pathology, Portuguese Institute for Oncology of Porto, Porto, Portugal"
        ],
        "Andreia Peixoto": [
            "Experimental Pathology and Therapeutics group, Portuguese Institute for Oncology of Porto, Porto, Portugal"
        ],
        "Beatriz Parreira": [
            "Experimental Pathology and Therapeutics group, Portuguese Institute for Oncology of Porto, Porto, Portugal"
        ],
        "José Manuel Correia da Costa": [
            "Center for the Study of Animal Science (ICETA), University of Porto, Porto, Portugal",
            "INSA, National Institute of Health, Porto, Portugal"
        ],
        "Paul J. Brindley": [
            "Research Center for Neglected Diseases of Poverty- Department of Microbiology, Immunology & Tropical Medicine, School of Medicine & Health Sciences, George Washington University, Washington, D.C., United States of America"
        ],
        "Carlos Lopes": [
            "Experimental Pathology and Therapeutics group, Portuguese Institute for Oncology of Porto, Porto, Portugal",
            "Abel Salazar Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal"
        ],
        "Lúcio L. Santos": [
            "Experimental Pathology and Therapeutics group, Portuguese Institute for Oncology of Porto, Porto, Portugal",
            "Health School of University of Fernando Pessoa, Porto, Portugal",
            "Department of Surgical Oncology, Portuguese Institute for Oncology, Porto, Portugal",
            "National Cancer Center, Luanda, Angol"
        ]
    }
}